US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 4.870
  • +0.060+1.25%
Close Dec 27 16:00 ET
  • 4.710
  • -0.160-3.29%
Post 16:49 ET
144.20MMarket Cap-6.28P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
529.48%6.01M
3.38%1.47M
296.75%1.92M
361.52%3.94M
121.44%1.08M
308.64%954.15K
1,935.76%1.43M
482.94K
518.36%854.15K
487.1K
Selling and administrative expenses
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
2,625.09%102.19K
1,502.85%60.11K
--42.6K
79.92%20.94K
--9.79K
-General and administrative expense
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
2,625.09%102.19K
1,502.85%60.11K
--42.6K
79.92%20.94K
--9.79K
Research and development costs
138.97%627.43K
-10.91%594.8K
82.59%804.02K
88.95%1.57M
-57.31%203.78K
14.28%262.56K
906.76%667.63K
--440.34K
558.70%833.21K
--477.31K
Other operating expenses
----
----
--370.5K
--1.77M
--479.55K
--589.4K
--698.6K
----
----
----
Operating profit
-529.48%-6.01M
-3.38%-1.47M
-296.75%-1.92M
-361.52%-3.94M
-121.44%-1.08M
-308.64%-954.15K
-1,935.76%-1.43M
-482.94K
-518.36%-854.15K
-487.1K
Net non-operating interest income expense
102.04%15.45K
120.55%25.49K
-4.34M
-1.64M
-761.82K
-757.17K
-124.05K
0
0
0
Non-operating interest income
--15.45K
--25.49K
----
----
----
--0
--0
----
----
----
Non-operating interest expense
--0
--0
--4.34M
--1.64M
--761.82K
--757.17K
--124.05K
--0
--0
--0
Other net income (expense)
-7.49M
Special income (charges)
----
----
----
---7.49M
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--7.49M
----
----
----
----
----
----
Income before tax
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
Income tax
Net income
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
Net income continuous Operations
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
---482.94K
-518.36%-854.15K
---487.1K
Minority interest income
Net income attributable to the parent company
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
-2,112.81%-1.55M
-482.94K
-518.36%-854.15K
-487.1K
Basic earnings per share
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
-632.89%-0.0578
-2,113.06%-0.0524
-0.0163
-518.37%-0.0288
-0.0165
Diluted earnings per share
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
-632.89%-0.0578
-2,113.06%-0.0524
-0.0163
-518.37%-0.0288
-0.0165
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 529.48%6.01M3.38%1.47M296.75%1.92M361.52%3.94M121.44%1.08M308.64%954.15K1,935.76%1.43M482.94K518.36%854.15K487.1K
Selling and administrative expenses 5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K2,625.09%102.19K1,502.85%60.11K--42.6K79.92%20.94K--9.79K
-General and administrative expense 5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K2,625.09%102.19K1,502.85%60.11K--42.6K79.92%20.94K--9.79K
Research and development costs 138.97%627.43K-10.91%594.8K82.59%804.02K88.95%1.57M-57.31%203.78K14.28%262.56K906.76%667.63K--440.34K558.70%833.21K--477.31K
Other operating expenses ----------370.5K--1.77M--479.55K--589.4K--698.6K------------
Operating profit -529.48%-6.01M-3.38%-1.47M-296.75%-1.92M-361.52%-3.94M-121.44%-1.08M-308.64%-954.15K-1,935.76%-1.43M-482.94K-518.36%-854.15K-487.1K
Net non-operating interest income expense 102.04%15.45K120.55%25.49K-4.34M-1.64M-761.82K-757.17K-124.05K000
Non-operating interest income --15.45K--25.49K--------------0--0------------
Non-operating interest expense --0--0--4.34M--1.64M--761.82K--757.17K--124.05K--0--0--0
Other net income (expense) -7.49M
Special income (charges) ---------------7.49M------------------0----
-Less:Other special charges --------------7.49M------------------------
Income before tax -250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K
Income tax
Net income -250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K
Net income continuous Operations -250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M---482.94K-518.36%-854.15K---487.1K
Minority interest income
Net income attributable to the parent company -250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M-2,112.81%-1.55M-482.94K-518.36%-854.15K-487.1K
Basic earnings per share -246.04%-0.24.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315-632.89%-0.0578-2,113.06%-0.0524-0.0163-518.37%-0.0288-0.0165
Diluted earnings per share -246.04%-0.24.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315-632.89%-0.0578-2,113.06%-0.0524-0.0163-518.37%-0.0288-0.0165
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List